Results 101 to 110 of about 16,409 (241)

The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD

International Journal of COPD, 2010
Barbara P Yawn1, Ibrahim Raphiou2, Judith S Hurley3, Anand A Dalal21Olmsted Medical Center, University of Minnesota, Rochester, Minnesota, USA; 2GlaxoSmithKline, Research Triangle Park, North Carolina, USA; 3Hurley Consulting, Placitas, New Mexico ...
Barbara P Yawn, Ibrahim Raphiou, Judith S Hurley, et al   +3 more
doaj  

Onset of Action and Pharmacokinetic Parameters of Azelastine Hydrochloride in Azelastine Nasal Spray and in a Combination Nasal Spray with Fluticasone Propionate [PDF]

, 2009
R. Berkowitz, Susan Braker, L. Fredane, Harry Sacks   +3 more
openalex   +1 more source

The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device [PDF]

, 2021
Donald P. Tashkin, Jill Ohar, Arkady Koltun, Richard Allan, Jonathan K. Ward   +4 more
openalex   +1 more source

Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers

Canadian Respiratory Journal, 1999
OBJECTIVE: To compare the efficacy and safety of a new combination Diskus inhaler containing both salmeterol 50 μg and fluticasone propionate 250 μg (Seretide) with the two drugs delivered via separate Diskus inhalers.
Kenneth R Chapman, Nils Ringdal, Vibeke Backer, Mona Palmqvist, Seppo Saarelainen, Mark Briggs   +5 more
doaj   +1 more source

Systematic review on inhaled corticosteroid monotherapy and its efficacy and safety in longterm treatment of patients with chronic obstructive pulmonary disease (COPD) [PDF]

--chronic obstructive pulmonary disease,COPD,corticosteroids,systematic review,chronisch obstruktive Lungenerkrankung,COPD,Kortikosteroid,systematischer ...
Buchberger, Barbara, Kossmann, Beate, Neumann, Anja, Niebuhr, Dea, Wasem, Jürgen   +4 more
core  

Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29‐02, a novel aqueous nasal spray [PDF]

, 2012
Hartmut Derendorf, Ullrich Munzel, U. Petzold, Joachim Maus, Hermann Mascher, Róbert Hermann, Jean Bousquet   +6 more
openalex   +1 more source

An efficacy and safety evaluation of montelukast + fluticasone propionate vs. fluticasone propionate in the treatment of cough variant asthma in children: a meta-analysis. [PDF]

BMC Pulm Med, 2023
Wei Z, Li S.
europepmc   +1 more source

Cost-effectiveness of fluticasone propionate/salmeterol (500/50μg) in the treatment of COPD [PDF]

, 2008
Stephanie Earnshaw, Michele Wilson, Anand A. Dalal, Mike Chambers, Priti Jhingran, Richard H. Stanford, Douglas W. Mapel   +6 more
openalex   +1 more source

Effects of nasal corticosteroids on boosts of systemic allergen-specific IgE production induced by nasal allergen exposure.

PLoS ONE, 2015
BackgroundAllergen exposure via the respiratory tract and in particular via the nasal mucosa boosts systemic allergen-specific IgE production. Intranasal corticosteroids (INCS) represent a first line treatment of allergic rhinitis but their effects on ...
Cornelia Egger, Christian Lupinek, Robin Ristl, Patrick Lemell, Friedrich Horak, Petra Zieglmayer, Susanne Spitzauer, Rudolf Valenta, Verena Niederberger   +8 more
doaj   +1 more source

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)

International Journal of COPD, 2016
Kai-Michael Beeh,1 Eric Derom,2 José Echave-Sustaeta,3 Lars Grönke,4 Alan Hamilton,5 Dongmei Zhai,6 Leif Bjermer71Insaf GmbH Institut für Atemwegsforschung, Wiesbaden, Germany; 2Department of Internal Medicine, Ghent University Hospital,
Beeh KM, Derom E, Echave-Sustaeta J, Grönke L, Hamilton A, Zhai D, Bjermer L   +6 more
doaj